Rutgers University Study of the Genetics of Kidney Disease
NCT07217535 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000
Last updated 2026-04-24
Summary
The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a diagnosis of kidney disease is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Conditions
- Kidney Disease
- Kidney Disease, Chronic
- Kidney Disease, End-Stage
- Kidney Diseases
- Kidney Diseases, Chronic
- Kidney Diseases,Cystic
Interventions
- GENETIC
-
Saliva sample
Saliva sample is sent via prepaid US Mail for DNA extraction
- OTHER
-
Health surveys
Health surveys are filled out online in the study portal.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Rutgers, The State University of New Jersey
lead OTHER
Principal Investigators
-
Tara Matise, Ph.D. · Rutgers, The State University of New Jersey
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-04-23
- Primary Completion
- 2028-10-31
- Completion
- 2028-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin
NCT00456053 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
NCT00596518 ·Status: COMPLETED ·Phase: PHASE1
-
Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease
NCT01156428 ·Status: COMPLETED
-
A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function
NCT02965040 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing the Performance of Serum Creatinine and Cystatin C-based GFR Estimations in Predicting Directly Measured GFR in Patients With or Without Nephrotic Syndrome
NCT06797609 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States
NCT04191824 ·Status: COMPLETED ·Phase: NA
-
Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted
NCT03832114 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade
NCT02384317 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
NCT07315360 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.
NCT06586216 ·Status: COMPLETED ·Phase: PHASE1
-
TruGraf® Long-term Clinical Outcomes Study
NCT04491552 ·Status: UNKNOWN
-
Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD
NCT02112136 ·Status: COMPLETED ·Phase: NA
-
Rituximab to Prevent Recurrence of Proteinuria
NCT01164098 ·Status: TERMINATED ·Phase: PHASE3
-
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease
NCT01974817 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Participants With Chronic Kidney Disease Previously Treated With REACT
NCT05694169 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants
NCT05291546 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
NCT01459250 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
NCT06790498 ·Status: ENROLLING_BY_INVITATION
-
Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis
NCT00883636 ·Status: TERMINATED
-
A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT05521191 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function
NCT00543075 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function
NCT01367509 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-Term Follow-Up Study of Participants Exposed to REACT
NCT05918523 ·Status: RECRUITING
-
Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease
NCT01630889 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
NCT01135316 ·Status: COMPLETED